Keywords: introgene, advance, thalassemia, dutch, company, reported, progression

IntroGene Advance In Thalassemia

Article | 30 October 1997

Dutch company IntroGene has reported progression in its beta-thalassemiaprogram. Using its vector system, a recombinant adeno-associated virus, it can deliver ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing